Evidence map›Paper›PMID 32888413›Full record

ArticleThe lancet. HIV2020

Community-wide HIV testing, linkage case management, and defaulter tracing in Bukoba, Tanzania: pre-intervention and post-intervention, population-based survey evaluation.

Claire Steiner, Duncan MacKellar, Haddi Jatou Cham, Oscar Ernest Rwabiyago, Haruka Maruyama, Omari Msumi, Sherri Pals, Rachel Weber, Gerald Kundi, Johnita Byrd and 6 more

Abstract read
In one paragraph

Article in The lancet. HIV, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Claire SteinerICAP at Columbia University, New York, NY, USA. Electronic address: cs3324@cumc.columbia.edu.
Duncan MacKellarDivision of Global HIV and TB, National Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Haddi Jatou ChamDivision of Global HIV and TB, National Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Oscar Ernest RwabiyagoUS Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Haruka MaruyamaICAP at Columbia University, Maseru, Lesotho.
Omari MsumiICAP at Columbia University, Maseru, Lesotho.
Sherri PalsDivision of Global HIV and TB, National Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Rachel WeberUS Centers for Disease Control and Prevention, Harare, Zimbabwe.
Gerald KundiICAP at Columbia University, Maseru, Lesotho.
Johnita ByrdICF International, Atlanta, GA, USA.
Kokuhumbya KazauraUS Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Caitlin Madevu-MatsonICAP at Columbia University, New York, NY, USA.
Fernando MoralesICAP at Columbia University, Maseru, Lesotho.
Jessica JustmanICAP at Columbia University, New York, NY, USA.
Thomas RutachunzibwaMinistry of Health, Community Development, Gender, Elderly and Children, Bukoba, Tanzania.
Anath RwebemberaNational AIDS Control Program, Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, Tanzania.

Funding

PS09-973 - IMPLEMENTATION OF PROGRAMS FOR THE PREVENTION, CARE AND TREATMENT OF HIV/AIDS IN - TANZANIAU2GPS001998 · PS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JUSTMAN, JESSICA E. · 2010 to 2015
$56.4M
CDC HHS 5UGPS001998-05NCHHSTP CDC HHS U2G PS001998
6 · The paper itself

Abstract

backgroundCommunity randomised trials have had mixed success in implementing combination prevention strategies that diagnose 90% of people living with HIV, initiate and retain on antiretroviral therapy (ART) 90% of those diagnosed, and achieve viral load suppression in 90% of those on ART (90-90-90). The Bukoba Combination Prevention Evaluation (BCPE) aimed to achieve 90-90-90 in Bukoba Municipal Council, Tanzania, by scaling up new HIV testing, linkage, and retention interventions.

methodWe did population-based, cross-sectional surveys before and after our community-wide intervention in Bukoba-a mixed urban and rural council of approximately 150 000 residents located on the western shore of Lake Victoria in Tanzania. BCPE interventions were implemented in 11 government-supported health-care facilities throughout Bukoba from Oct 1, 2014, to March 31, 2017, when national ART-eligibility guidelines expanded from CD4 counts of less than 350 cells per μL (Oct 1, 2014-Dec 31, 2015) and 500 or less cells per μL (Jan 1, 2016-Sept 30, 2016) to any CD4 cell count (test and treat, Oct 1, 2016-March 31, 2017). We used pre-intervention (Nov 4, 2013-Jan 25, 2014) and post-intervention (June 21, 2017-Sept 20, 2017) population-based household surveys to assess population prevalence of undiagnosed HIV infection and ART coverage, and progress towards 90-90-90, among residents aged 18-49 years.

findingsDuring the 2·5-year intervention, BCPE did 133 695 HIV tests, diagnosed and linked 3918 people living with HIV to HIV care at 11 Bukoba facilities, and returned to HIV care 604 patients who had stopped care. 4795 and 5067 residents aged 18-49 years participated in pre-intervention and post-intervention surveys. HIV prevalence before and after the intervention was similar: pre-intervention 8·9% (95% CI 7·5-10·4); post-intervention 8·4% (6·9-9·9). Prevalence of undiagnosed HIV infection decreased from 4·7% to 2·0% (prevalence ratio 0·42, 95% CI 0·31-0·57), and current ART use among all people living with HIV increased from 32·2% to 70·9% (2·20, 1·82-2·66) overall, 23·0% to 62·1% among men (2·70, 1·84-3·96), and 16·7% to 64·4% among people aged 18-29 years (3·87, 2·54-5·89). Of 436 and 435 people living with HIV aged 18-49 years who participated in pre-intervention and post-intervention surveys, previous HIV diagnosis increased from 47·4% (41·3-53·4) to 76·2% (71·8-80·6), ART use among diagnosed people living with HIV increased from 68·0% (60·9-75·2) to 93·1% (90·2-96·0), and viral load suppression of those on ART increased from 88·7% (83·6-93·8) to 91·3% (88·6-94·1).

interpretationBCPE findings suggest scaling up recommended HIV testing, linkage, and retention interventions can help reduce prevalence of undiagnosed HIV infection, increase ART use among all people living with HIV, and make substantial progress towards achieving 90-90-90 in a relatively short period. BCPE facility-based testing and linkage interventions are undergoing national scale up to help achieve 90-90-90 in Tanzania.

fundingUS Presidents' Emergency Plan for AIDS Relief.

Indexed as

AdolescentAdultCase ManagementCD4 Lymphocyte CountCross-Sectional StudiesDiagnostic Tests, RoutineFemaleGeography, MedicalHIV InfectionsHumansMaleMass ScreeningPopulation SurveillancePrevalenceRural PopulationTanzania

Identifiers

PMID32888413
PMCPMC7748378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.